Diseases, Conditions, Syndromes

Adding tirzepatide to insulin glargine ups glycemic control in T2DM

(HealthDay)—The addition of subcutaneous tirzepatide versus placebo to titrated insulin glargine results in significant improvements in glycemic control among patients with type 2 diabetes and inadequate glycemic control, ...

Oncology & Cancer

A blood test could predict who benefits from immunotherapy

A test which detects changing levels of tumor fragments in the blood may be an easy, non-invasive and quick way to predict who will benefit from immunotherapy, a treatment option for advanced cancers.

Immunology

Molecular 'culprit' caught driving cell death and inflammation

A WEHI-led study has identified a molecular 'culprit' responsible for causing damaging levels of cell death and inflammation in the body. The findings could lead to improved treatment options for a range of conditions driven ...

page 11 from 40